Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 30 (9) , 127061
Abstract
No abstract availableKeywords
Funding Information
- Chinese Academy of Sciences (XDA12020368)
- Ministry of Science and Technology of the People's Republic of China
- State Key Laboratory of Natural Medicines (SKLNMZZRC07)
- National Key Research and Development Program of China (2017YFB0202600)
This publication has 36 references indexed in Scilit:
- Development of Homogeneous Nonradioactive Methyltransferase and Demethylase Assays Targeting Histone H3 Lysine 4SLAS Discovery, 2012
- The Structure of NSD1 Reveals an Autoregulatory Mechanism Underlying Histone H3K36 MethylationJournal of Biological Chemistry, 2011
- Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma proteinThe EMBO Journal, 2010
- The Cellular Lysine Methyltransferase Set7/9-KMT7 Binds HIV-1 TAR RNA, Monomethylates the Viral Transactivator Tat, and Enhances HIV TranscriptionCell Host & Microbe, 2010
- Regulation of NF-κB activity through lysine monomethylation of p65Proceedings of the National Academy of Sciences, 2009
- Negative regulation of NF‐κB action by Set9‐mediated lysine methylation of the RelA subunitThe EMBO Journal, 2009
- Methyltransferase Set7/9 Maintains Transcription and Euchromatin Structure at Islet-Enriched GenesDiabetes, 2009
- Regulation of Estrogen Receptor α by the SET7 Lysine MethyltransferaseMolecular Cell, 2008
- Chromatin Modifications and Their FunctionCell, 2007
- SET Domain-containing Protein, G9a, Is a Novel Lysine-preferring Mammalian Histone Methyltransferase with Hyperactivity and Specific Selectivity to Lysines 9 and 27 of Histone H3Journal of Biological Chemistry, 2001